Rakesh K. Jain

190.7k citations
862 papers · 134.8k indexed · 75 hit papers · h-index 170
Co-authors
Dai FukumuraPeter CarmelietTriantafyllos StylianopoulosLance L. MunnYves BoucherDan G. DudaD.E. DolmansFan Yuan
Topics
Angiogenesis and VEGF in Cancer (206 papers)Cancer, Hypoxia, and Metabolism (159 papers)Glycosylation and Glycoproteins Research (61 papers)
Cited by
Cancer ResearchBiomaterialsOncology
Journals
NatureScienceNew England Journal of Medicine
Partner nations
United StatesIndiaCyprus

In The Last Decade

Rakesh K. Jain

841 papers receiving 132.4k citations

Hit Papers

Angiogenesis in cancer and other diseases1974202619912008200020032005201120182.0k4.0k6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiogenesis in cancer and other diseases
    2000 7.3k citations Rakesh K. Jain et al. profile →
  2. Photodynamic therapy for cancer
    2003 5.7k citations Dai Fukumura, Rakesh K. Jain et al. profile →
  3. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
    2005 4.2k citations Rakesh K. Jain Science profile →
  4. Molecular mechanisms and clinical applications of angiogenesis
    2011 4.2k citations Rakesh K. Jain et al. profile →
  5. Understanding the tumor immune microenvironment (TIME) for effective therapy
    2018 4.0k citations Rakesh K. Jain et al. profile →
  6. Delivering nanomedicine to solid tumors
    2010 2.5k citations Rakesh K. Jain, Triantafyllos Stylianopoulos profile →
  7. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
    1998 2.1k citations Dai Fukumura, Rakesh K. Jain et al. profile →
  8. Molecular regulation of vessel maturation
    2003 1.9k citations Rakesh K. Jain profile →
  9. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
    1998 1.9k citations Rakesh K. Jain et al. Proceedings of the National Academy of Sciences profile →
  10. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
    2001 1.7k citations Rakesh K. Jain profile →
  11. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
    1995 1.4k citations Dai Fukumura, Rakesh K. Jain et al. profile →
  12. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
    2018 1.4k citations Dai Fukumura, Dan G. Duda et al. profile →
  13. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
    1997 1.3k citations Rakesh K. Jain et al. profile →
  14. Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
    2000 1.3k citations Rakesh K. Jain et al. profile →
  15. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
    2011 1.3k citations Rakesh K. Jain et al. profile →
  16. Normalization of the Vasculature for Treatment of Cancer and Other Diseases
    2011 1.2k citations Dan G. Duda, Lance L. Munn et al. profile →
  17. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
    2013 1.2k citations Rakesh K. Jain et al. Cancer Research profile →
  18. Compact high-quality CdSe–CdS core–shell nanocrystals with narrow emission linewidths and suppressed blinking
    2013 1.2k citations Vikash P. Chauhan, Dai Fukumura et al. profile →
  19. Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
    2014 1.2k citations Rakesh K. Jain profile →
  20. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
    2019 1.2k citations Rakesh K. Jain et al. profile →
  21. Transport of molecules in the tumor interstitium: a review.
    1987 1.1k citations Rakesh K. Jain profile →
  22. Angiogenesis in brain tumours
    2007 1.1k citations Rakesh K. Jain, Emmanuelle di Tomaso et al. profile →
  23. The role of nitric oxide in tumour progression
    2006 1.0k citations Dai Fukumura, Rakesh K. Jain et al. profile →
  24. Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
    1997 1.0k citations Dai Fukumura, Rakesh K. Jain et al. Science profile →
  25. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
    2004 976 citations Sung‐Suk Chae, Michael F. Booth et al. profile →
  26. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
    2004 943 citations Yves Boucher, Rakesh K. Jain et al. Cancer Research profile →
  27. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
    2012 918 citations Vikash P. Chauhan, Triantafyllos Stylianopoulos et al. profile →
  28. Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
    2013 899 citations Rakesh K. Jain profile →
  29. Multistage nanoparticle delivery system for deep penetration into tumor tissue
    2011 895 citations Triantafyllos Stylianopoulos, John D. Martin et al. Proceedings of the National Academy of Sciences profile →
  30. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
    2012 828 citations Walid S. Kamoun, Marek Ancukiewicz et al. Proceedings of the National Academy of Sciences profile →
  31. Barriers to Drug Delivery in Solid Tumors
    1994 826 citations Rakesh K. Jain profile →
  32. Lessons from phase III clinical trials on anti-VEGF therapy for cancer
    2006 823 citations Rakesh K. Jain, Dan G. Duda et al. profile →
  33. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
    2001 822 citations Dai Fukumura, Rakesh K. Jain et al. Proceedings of the National Academy of Sciences profile →
  34. Tumor Induction of VEGF Promoter Activity in Stromal Cells
    1998 795 citations Dai Fukumura, Rakesh K. Jain et al. profile →
  35. Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
    2002 771 citations Rakesh K. Jain et al. profile →
  36. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
    1994 769 citations Rakesh K. Jain et al. profile →
  37. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
    2002 767 citations Emmanuelle di Tomaso, Edward B. Brown et al. Science profile →
  38. The Role of Mechanical Forces in Tumor Growth and Therapy
    2014 754 citations Rakesh K. Jain, John D. Martin et al. profile →
  39. Transport of molecules across tumor vasculature
    1987 695 citations Rakesh K. Jain profile →
  40. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
    2003 688 citations Edward B. Brown, Trevor D. McKee et al. profile →
  41. Strategies for advancing cancer nanomedicine
    2013 684 citations Vikash P. Chauhan, Rakesh K. Jain profile →
  42. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
    2012 682 citations Triantafyllos Stylianopoulos, John D. Martin et al. Proceedings of the National Academy of Sciences profile →
  43. Cancer cells compress intratumour vessels
    2004 660 citations Emmanuelle di Tomaso, Rakesh K. Jain et al. profile →
  44. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.
    1990 649 citations Yves Boucher, Rakesh K. Jain et al. profile →
  45. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
    2011 600 citations Vikash P. Chauhan, Yves Boucher et al. Proceedings of the National Academy of Sciences profile →
  46. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
    1996 572 citations Rakesh K. Jain et al. Proceedings of the National Academy of Sciences profile →
  47. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
    2018 565 citations Jessica A. Carr, Daniel Franke et al. Proceedings of the National Academy of Sciences profile →
  48. Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
    2007 559 citations Dai Fukumura, Rakesh K. Jain profile →
  49. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    2000 551 citations Emmanuelle di Tomaso, Marek Ancukiewicz et al. profile →
  50. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
    2009 548 citations Triantafyllos Stylianopoulos, Lance L. Munn et al. profile →
  51. Creation of long-lasting blood vessels
    2004 543 citations Dai Fukumura, Rakesh K. Jain et al. profile →
  52. Physical traits of cancer
    2020 536 citations Lance L. Munn, Rakesh K. Jain et al. Science profile →
  53. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
    2020 535 citations John D. Martin, Triantafyllos Stylianopoulos et al. profile →
  54. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
    2000 519 citations Emmanuelle di Tomaso, Rakesh K. Jain et al. Proceedings of the National Academy of Sciences profile →
  55. Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
    2013 517 citations Dan G. Duda, Dai Fukumura et al. Cancer Research profile →
  56. Transport of Molecules, Particles, and Cells in Solid Tumors
    1999 503 citations Rakesh K. Jain profile →
  57. Microvascular permeability of normal and neoplastic tissues
    1986 500 citations Rakesh K. Jain et al. profile →
  58. Mechanical compression drives cancer cells toward invasive phenotype
    2011 471 citations Yves Boucher, Rakesh K. Jain et al. Proceedings of the National Academy of Sciences profile →
  59. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.
    1990 458 citations Rakesh K. Jain profile →
  60. Physiologically Based Pharmacokinetic Modeling: Principles and Applications
    1983 454 citations Rakesh K. Jain et al. profile →
  61. HCC and angiogenesis: possible targets and future directions
    2011 448 citations Andrew X. Zhu, Dan G. Duda et al. profile →
  62. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside
    2018 425 citations Triantafyllos Stylianopoulos, Lance L. Munn et al. profile →
  63. Spontaneous rupture of thin liquid films
    1974 420 citations Rakesh K. Jain et al. profile →
  64. The biology of brain metastases—translation to new therapies
    2011 419 citations Dai Fukumura, Rakesh K. Jain et al. profile →
  65. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
    2018 414 citations Rakesh K. Jain et al. profile →
  66. Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
    2011 390 citations Vikash P. Chauhan, Dai Fukumura et al. profile →
  67. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
    2019 371 citations John D. Martin, Rakesh K. Jain et al. profile →
  68. Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
    2006 335 citations Trevor D. McKee, Paola Grandi et al. Cancer Research profile →
  69. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
    2005 322 citations John P. Zimmer, Dan G. Duda et al. profile →
  70. A Nanoparticle Size Series for In Vivo Fluorescence Imaging
    2010 288 citations Vikash P. Chauhan, Numpon Insin et al. profile →
  71. A metastasis map of human cancer cell lines
    2020 272 citations Rakesh K. Jain et al. profile →
  72. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
    2022 254 citations Rakesh K. Jain et al. Clinical Cancer Research profile →
  73. The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
    2020 244 citations Rakesh K. Jain, Dan G. Duda et al. profile →
  74. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
    2019 198 citations Triantafyllos Stylianopoulos, Fotios Mpekris et al. Proceedings of the National Academy of Sciences profile →
  75. Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer
    2025 19 citations Chrysovalantis Voutouri, Triantafyllos Stylianopoulos et al. profile →

Peers

Rakesh K. Jain
Comparison fields: 5 of 214
  • Molecular Biology 56.7k
  • Biomedical Engineering 37.4k
  • Oncology 34.7k
  • Cancer Research 27.5k
  • Biomaterials 20.2k
Replace Judah Folkman with:
Judah Folkman United States
Douglas Hanahan United States
Robert A. Weinberg United States
Peter Carmeliet Belgium
Zena Werb United States
Ralph Weissleder United States
Hans Clevers Netherlands
Napoleone Ferrara United States
Irving L. Weissman United States
Róbert Langer United States
Rakesh K. Jain relative to Judah Folkman United States Judah Folkman's profile →
Citations per field
00.5×5×12.2×
Judah Folkman · 1×
Citations per year

Countries citing papers authored by Rakesh K. Jain

Since Specialization
Citations

This map shows the geographic impact of Rakesh K. Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh K. Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh K. Jain more than expected).

Fields of papers citing papers by Rakesh K. Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakesh K. Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh K. Jain. The network helps show where Rakesh K. Jain may publish in the future.

Co-authorship network of co-authors of Rakesh K. Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh K. Jain. A scholar is included among the top collaborators of Rakesh K. Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh K. Jain. Rakesh K. Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Forehead flap reconstruction for post traumatic nasal defects: functional and aesthetic outcomes
2023 ·International Surgery Journal ·(unknown),Rakesh K. Jain,(unknown),(unknown)
0
2
In silico dynamics of COVID-19 phenotypes for optimizing clinical management
2021 ·Proceedings of the National Academy of Sciences ·Chrysovalantis Voutouri,Mohammad R. Nikmaneshi,C. Corey Hardin,Ankit Patel,Ashish Verma,Melin J. Khandekar,Sayon Dutta,Triantafyllos Stylianopoulos,Lance L. Munn,Rakesh K. Jain
34
3
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
2019 ·Proceedings of the National Academy of Sciences ·Ivy X. Chen,Vikash P. Chauhan,Jessica M. Posada,Mei Rosa Ng,Michelle Wu,Pichet Adstamongkonkul,Peigen Huang,Neal I. Lindeman,Róbert Langer,Rakesh K. Jain
307
4
Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
2019 ·Clinical Cancer Research ·Elizabeth R. Gerstner,Kyrre E. Emblem,Ken Chang,(unknown),Yi‐Fen Yen,Andrew Beers,Jörg Dietrich,Scott R. Plotkin,Ciprian Catana,Jacob M. Hooker,Dan G. Duda,Bruce R. Rosen,Jayashree Kalpathy–Cramer,Rakesh K. Jain,Tracy T. Batchelor
40
5
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine greenbreakdown →
2018 ·Proceedings of the National Academy of Sciences ·Jessica A. Carr,Daniel Franke,Justin R. Caram,Collin F. Perkinson,(unknown),Vasileios Askoxylakis,Meenal Datta,Dai Fukumura,Rakesh K. Jain,Moungi G. Bawendi,Oliver T. Bruns†
565
6
Collaboration in Cancer Trials (October 26–27, 2015)
2015 ·The Oncologist ·Michel Sadelain,David Avigan,Priscilla K. Brastianos,Leif W. Ellisen,Alan D. D’Andrea,Lee Zou,Rakesh K. Jain,Sridhar Ramaswamy,Geoffrey M. Wahl
2
7
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
2013 ·Clinical Cancer Research ·Andrew X. Zhu,Richard S. Finn,Mary F. Mulcahy,Jayne Gurtler,Weijing Sun,Jonathan D. Schwartz,Rita P. Dalal,Adarsh Joshi,Rebecca R. Hozak,Yihuan Xu,Marek Ancukiewicz,Rakesh K. Jain,F. Warren Nugent,Dan G. Duda,Keith Stuart
122
8
Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
2013 ·Clinical Cancer Research ·Andrew X. Zhu,Marek Ancukiewicz,Jeffrey G. Supko,Dushyant V. Sahani,Lawrence S. Blaszkowsky,Jeffrey A. Meyerhardt,Thomas A. Abrams,Nadine J. McCleary,Pankaj Bhargava,Alona Muzikansky,Susan Sheehan,Eileen Regan,(unknown),(unknown),Charles S. Fuchs,David P. Ryan,Rakesh K. Jain,Dan G. Duda
55
9
Transgenic Mice for cGMP Imaging
2013 ·Circulation Research ·Martin Thunemann,Lai Wen,Matthias Hillenbrand,(unknown),Susanne Feil,Thomas Ott,Xiaoxing Han,Dai Fukumura,Rakesh K. Jain,Michael Russwurm,Cor de Wit,Robert Feil
61
10
Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
2013 ·Cancer Research ·Triantafyllos Stylianopoulos,John D. Martin,Matija Snuderl,Fotios Mpekris,Saloni R. Jain,Rakesh K. Jain
352
11
Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2011 ·Cancer Research ·(unknown),Ciprian Catana,Eva‐Maria Ratai,Ovidiu C. Andronesi,Dominique Jennings,Tracy T. Batchelor,Rakesh K. Jain,A. Gregory Sorensen
36
12
Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape
2011 ·Cancer Research ·Emmanuelle di Tomaso,Matija Snuderl,Walid S. Kamoun,Dan G. Duda,Pavan K. Auluck,Ladan Fazlollahi,Ovidiu C. Andronesi,Matthew P. Frosch,Patrick Y. Wen,Scott R. Plotkin,E. Tessa Hedley‐Whyte,A. Gregory Sorensen,Tracy T. Batchelor,Rakesh K. Jain
156
13
Angiopoietin-2 Interferes with Anti-VEGFR2–Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
2010 ·Clinical Cancer Research ·Sung‐Suk Chae,Walid S. Kamoun,Christian T. Farrar,Nathaniel D. Kirkpatrick,Elisabeth Niemeyer,Annemarie M.A. de Graaf,A. Gregory Sorensen,Lance L. Munn,Rakesh K. Jain,Dai Fukumura
115
14
Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
2010 ·Cancer Research ·Hon Kit Wong,Johanna Lahdenranta,Walid S. Kamoun,Annie W. Chan,Andrea I. McClatchey,Scott R. Plotkin,Rakesh K. Jain,Emmanuelle di Tomaso
85
15
p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis
2009 ·Science ·David G. Kirsch,Philip M. Santiago,Emmanuelle di Tomaso,Julie M. Sullivan,Wu-Shiun Hou,Talya L. Dayton,Laura B. Jeffords,(unknown),Kim L. Mercer,(unknown),Osamu Takeuchi,Stanley J. Korsmeyer,Roderick T. Bronson,Carla F. Kim,Kevin M. Haigis,Rakesh K. Jain,Tyler Jacks
1
16
A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
2009 ·Cancer Research ·A. Gregory Sorensen,Tracy T. Batchelor,Weiting Zhang,(unknown),(unknown),Meiyun Wang,Dominique Jennings,Patrick Y. Wen,Johanna Lahdenranta,Marek Ancukiewicz,Emmanuelle di Tomaso,Dan G. Duda,Rakesh K. Jain
291
17
Matrix Metalloproteinases-1 and -8 Improve the Distribution and Efficacy of an Oncolytic Virus
2007 ·Cancer Research ·(unknown),Yves Boucher,Rakesh K. Jain
136
18
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vectorbreakdown →
2006 ·Cancer Research ·Trevor D. McKee,Paola Grandi,(unknown),George Alexandrakis,Numpon Insin,John P. Zimmer,Moungi G. Bawendi,Yves Boucher,Xandra O. Breakefield,Rakesh K. Jain
335
19
Lack of Telopeptides in Fibrillar Collagen I Promotes the Invasion of a Metastatic Breast Tumor Cell Line
2005 ·Cancer Research ·Zoe N. Demou,Michael M. Awad,Trevor D. McKee,Jean Yannis Perentes,(unknown),Lance L. Munn,Rakesh K. Jain,Yves Boucher
36
20
Differential Transplantability of Tumor-Associated Stromal Cells
2004 ·Cancer Research ·Dan G. Duda,Dai Fukumura,Lance L. Munn,Michael F. Booth,Edward B. Brown,Peigen Huang,Brian Seed,Rakesh K. Jain
41

About Rakesh K. Jain

Rakesh K. Jain is a scholar working on Cancer Research, Oncology and Modeling and Simulation, having authored 862 papers that have together received 134.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (206 papers), Cancer, Hypoxia, and Metabolism (159 papers) and Glycosylation and Glycoproteins Research (61 papers). The work is most often cited by research in Cancer Research (27.5k citations), Biomaterials (20.2k citations) and Oncology (34.7k citations). Rakesh K. Jain has collaborated with scholars based in United States, India and Cyprus. Frequent co-authors include Dai Fukumura, Peter Carmeliet, Triantafyllos Stylianopoulos, Lance L. Munn, Yves Boucher, Dan G. Duda, D.E. Dolmans, Fan Yuan, Vikash P. Chauhan and Emmanuelle di Tomaso. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judah FolkmanBreakdown of academic impact, for papers by Douglas HanahanBreakdown of academic impact, for papers by Robert A. WeinbergBreakdown of academic impact, for papers by Peter CarmelietBreakdown of academic impact, for papers by Zena WerbBreakdown of academic impact, for papers by Ralph WeisslederBreakdown of academic impact, for papers by Hans CleversBreakdown of academic impact, for papers by Napoleone FerraraBreakdown of academic impact, for papers by Irving L. WeissmanBreakdown of academic impact, for papers by Róbert Langer
Rankless by CCL
2026